Construction and analysis of multidrug resistance transgenic mice.
Evans
G L
GL
Clinical Gene Therapy Branch, National Center for Human Genome Research, Bethesda, Maryland 20892, USA.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis* / Q000235:genetics; D000818:Animals; D017931:DNA Primers; D015342:DNA Probes; D018076:DNA, Complementary; D018432:Drug Resistance, Multiple / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D007962:Leukocytes / Q000502:physiology; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control; D051379:Mice; D008822:Mice, Transgenic; D009928:Organ Specificity; D016133:Polymerase Chain Reaction / Q000379:methods; D012313:RNA / Q000096:biosynthesis; D013997:Time Factors; D014158:Transcription, Genetic; D014700:Verapamil / Q000633:toxicity
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D017931:DNA Primers; D015342:DNA Probes; D018076:DNA, Complementary; D012313:RNA; D014700:Verapamil